Multiple Sclerosis Market in the US 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Multiple Sclerosis Market in the US 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on theMultiple Sclerosis Market in

the US 2015-2019,please mail us at

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “No standard treatment procedures for multiple sclerosis are present in the market. The available drugs only provide symptomatic relief and do not completely cure the disease. The presence of a robust product pipeline with drugs that can treat the disease completely propels market growth. The growing population of individuals with the disease also boosts market growth.”

• Multiple sclerosis is a chronic inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is potentially debilitating and causes disruption in the communicating and coordinating functions of the body.

• Technavio's analysts forecast the multiple sclerosis market in the US to grow at a CAGR of 4.64% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Multiple Sclerosis Market in the US 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and

for a full list of vendors view our

report:

Multiple Sclerosis Market in the US 2015-2019

Bayer

Biogen

Merck Serono

Bayer was founded in 1863 and is headquartered in Leverkusen, Germany. It develops, produces, and markets healthcare and agricultural products and high-tech polymer materials.

Biogen is a global biotechnology company engaged in the developing, manufacturing, and marketing of therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders.

Merck Serono was incorporated in 2007 and is headquartered in Geneva, Switzerland. Merck Serono is a biopharmaceutical company that focuses on the discovery, development, manufacturing, and marketing of pharmaceuticals.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The multiple sclerosis market in the US will likely grow moderately during the forecast period because of the presence of unmet medical needs and a robust drug pipeline in the market.

• The growing patient population and increased number of patient assistance programs will also propel market growth in the future.

• However, unknown disease etiology, the unpredictable nature of the disease, and difficulty in disease diagnosis will restrict market growth.

• These constraining factors make it hard for pharmaceutical companies to develop safe and efficient drugs that target the cause of the disease and lead to faster remission.

USA – CANADA – UK – CHINA – INDIA

Key Buying Criteria

Parameter Details

Availability Drugs for the treatment of multiple sclerosis should be readily available in the market.

Efficacy Drugs for the treatment of multiple sclerosis should be efficient and show positive results.

Affordability Drugs for the treatment of multiple sclerosis should be priced reasonably.

Side Effects Drugs for the treatment of multiple sclerosis should be safe and have minimum side effects.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Multiple Sclerosis Market in the US 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION